Evidence map›Paper›PMID 20859999›Full record

ArticleHead & neck2011

Prognostic value of heparanase expression and cellular localization in oral cancer.

Yoav Leiser, Imad Abu-El-Naaj, Edmond Sabo, Sharon Akrish, Neta Ilan, Ofer Ben-Izhak, Micha Peled, Israel Vlodavsky

Abstract readComparative Study
In one paragraph

Article in Head & neck, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Heparanase and the hallmarks of cancer.Journal of translational medicine · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  7. Heparanase expression correlates with poor survival in oral mucosal melanoma.Medical oncology (Northwood, London, England) · 2013
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yoav LeiserDepartment of Oral and Maxillofacial Surgery, Rambam Medical Center, Post Office Box 9602, Haifa, Israel.
Imad Abu-El-Naaj
Edmond Sabo
Sharon Akrish
Neta Ilan
Ofer Ben-Izhak
Micha Peled
Israel Vlodavsky
Rambam Health Care Campus · ILTechnion – Israel Institute of Technology · IL

Funding

Regulation of heparanase in cancer progressionR01CA106456 · NCI · TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY · PI VLODAVSKY, ISRAEL · 2004 to 2013
$1.7M
NCI NIH HHS R01 CA106456NCI NIH HHS R01-CA106456
6 · The paper itself

Abstract

backgroundMetastases formation depends on the ability of tumor cells to invade basement membranes in a process involving enzymes capable of degrading extracellular matrix components.

methodsWe examined the expression of heparanase in oral carcinomas and correlated its staining extent, intensity, and cellular localization with patients' outcome.

resultsQuantitative real-time polymerase chain reaction (PCR) revealed over 4-fold increase in heparanase levels in oral carcinomas compared to adjacent normal tissue. Normal oral epithelium was found negative for heparanase, while all oral carcinomas stained positively for heparanase. Heparanase staining was associated with Ki67 staining, a measure of cell proliferation. Notably, whereas cytoplasmic localization of heparanase was associated with high-grade carcinomas, nuclear localization of the enzyme was found primarily in low-grade, well-differentiated tumors, and in all oral verrucous carcinomas.

conclusionExpression level and cellular localization of heparanase could serve as an important diagnostic marker in patients with oral cancer.

Indexed as

Analysis of VarianceBiomarkers, TumorBiopsy, NeedleDisease-Free SurvivalFemaleGene Expression Regulation, NeoplasticGlucuronidaseHeparanaseHumansImmunohistochemistryKaplan-Meier EstimateMaleMouth NeoplasmsPredictive Value of TestsPrognosisProportional Hazards ModelsBiomarkers, TumorGlucuronidaseHeparanase

Identifiers

PMID20859999
PMCPMC3010289
OpenAlexW2079980239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.